MARY LITTLEHORN: Open Payments
NPI 1952645558 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,366 in 46 payments from 18 companies in 2025. Trend: 2023 $1,304 · 2024 $1,137 · 2025 $1,366
Food & beverage: $1,169Education: $197
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $430 |
| Janssen Biotech, Inc. | 5 | $185 |
| Galderma Laboratories, L.P. | 3 | $135 |
| SANOFI-AVENTIS U.S. LLC | 1 | $97 |
| LEO Pharma Inc. | 3 | $91 |
| ABBVIE INC. | 3 | $73 |
| Incyte Corporation | 3 | $62 |
| PFIZER INC. | 3 | $50 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $48 |
| Amgen Inc. | 2 | $37 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, SKYRIZI, OPZELURA, ANZUPGO, CIBINQO, OTEZLA.
Industry payments across AZ — which companies pay providers there.
